Mobile Gamma Cameras Market Size, Trends 2025-2033

The global mobile gamma cameras market is experiencing significant growth, driven by technological advancements in medical imaging and a rising prevalence of chronic diseases. Valued at USD 57.8 million in 2024, the market is projected to reach USD 79.2 million by 2033, exhibiting a CAGR of 3.39% from 2025 to 2033. The increasing demand for portable diagnostic devices, especially in oncology and cardiology, along with supportive government healthcare initiatives, are key factors propelling this growth. North America currently leads the market, holding over 35.0% share in 2024, attributed to its advanced healthcare infrastructure and rapid adoption of modern medical technologies. 

STUDY ASSUMPTION YEARS

• Base Year: 2024
• Historical Years: 2019-2024
• Forecast Years: 2025-2033

MOBILE GAMMA CAMERAS MARKET KEY TAKEAWAYS

• Market Size & Growth: The market was valued at USD 57.8 million in 2024 and is expected to reach USD 79.2 million by 2033, growing at a CAGR of 3.39% during 2025-2033.
• Regional Dominance: North America holds the largest market share, over 35.0% in 2024, due to advanced healthcare infrastructure and high adoption of modern medical technologies.
• Product Segmentation: Single-head mobile gamma cameras dominate the product segment, accounting for 62.9% market share in 2024, owing to their cost-effectiveness and versatility.
• Application Insights: Thyroid scanning leads the application segment, driven by the increasing prevalence of thyroid disorders and the need for accurate diagnostic imaging.
• End User Analysis: Hospitals are the primary end users, holding 41.3% market share in 2024, due to their extensive infrastructure and large patient volume.
• Technological Advancements: Integration of solid-state detectors, AI-powered imaging software, and improved energy resolution are enhancing diagnostic efficiency and accuracy.
• Portability Trend: The shift towards portable and point-of-care diagnostic solutions is increasing the adoption of mobile gamma cameras in various clinical settings.

MARKET GROWTH FACTORS

1. Growing incidence of cancer and cardiovascular diseases

The mobile gamma cameras market is experiencing impressive growth, primarily fueled by rapid technological advancements that are boosting diagnostic capabilities and clinical efficiency. A breakthrough is the improvement in spatial resolution, which enables clinicians to capture clearer and more precise images, allowing for early and accurate detection of abnormalities. This is especially crucial in fields like oncology, cardiology, and neurology, where timely diagnoses can significantly influence treatment outcomes. Moreover, the integration of mobile gamma cameras with cutting-edge digital systems is streamlining workflows, enhancing image storage and sharing, and making remote consultations easier. These innovations not only enhance the overall performance of mobile gamma cameras but also make them more user-friendly and accessible, leading to their wider adoption in various healthcare environments.

2. Increased demand for portable diagnostic solutions

The mobile gamma cameras market is experiencing impressive growth, fueled by rapid technological advancements and an increasing demand for portable diagnostic solutions. Unlike their traditional counterparts, mobile systems offer enhanced flexibility and user-friendliness, making them perfect for both outpatient care and centralized healthcare environments. Their compact and lightweight design allows clinicians to conduct high-quality nuclear imaging right at the patient's bedside, which boosts workflow efficiency and minimizes the need for patient transport. These devices also facilitate quicker diagnosis and treatment planning, which is especially advantageous in emergencies and for patients with limited mobility. As healthcare providers place a greater emphasis on convenience, cost-effectiveness, and patient-centered care, the use of mobile gamma cameras is on the rise, establishing them as a valuable alternative to conventional fixed imaging systems.

3. Improvements in imaging modalities

The mobile gamma cameras market is on a significant upswing, driven by continuous technological innovations that are changing the landscape of imaging methods and broadening their clinical applications. A key development has been the boost in spatial resolution, which allows healthcare professionals to capture sharper and more detailed images, leading to better diagnostic accuracy and improved patient outcomes. Additionally, the merging of gamma cameras with advanced digital systems has simplified image processing, storage, and sharing, ensuring smooth integration with hospital information systems and electronic medical records. These advancements not only shorten diagnostic times but also aid in real-time decision-making, making mobile gamma cameras more effective across various medical settings, including emergency care and bedside monitoring. All these improvements are encouraging wider use and reinforcing their significance in modern nuclear medicine practices.

Request for a sample copy of this report: 

https://www.imarcgroup.com/mobile-gamma-cameras-market/requestsample

MARKET SEGMENTATION

By Product:

• Single-head Mobile Gamma Cameras: Dominating the market with 62.9% share in 2024, these cameras are cost-effective and versatile, suitable for various clinical applications.
• Dual-head Mobile Gamma Cameras: Offer enhanced imaging capabilities, providing better resolution and faster scanning times for complex diagnostic procedures.
• Triple-head Mobile Gamma Cameras: Provide superior image quality and are used in advanced diagnostic applications requiring high precision.
• Handheld Mobile Gamma Camera: Compact and portable, ideal for intraoperative imaging and point-of-care diagnostics in diverse clinical settings.

By Application:

• Cardiac Imaging: Utilized for assessing myocardial perfusion and detecting coronary artery diseases, aiding in timely intervention.
• Breast Imaging: Assists in the detection and localization of breast tumors, especially in dense breast tissues where mammography may be less effective.
• Thyroid Scanning: Essential for diagnosing thyroid disorders, including hyperthyroidism and thyroid nodules, by evaluating gland function and structure.
• Kidney Scanning: Helps in assessing renal function and detecting abnormalities such as obstructions or infections.
• Intraoperative Imaging: Provides real-time imaging during surgical procedures, enhancing precision and outcomes.
• Brain Imaging: Used in the evaluation of neurological conditions, including epilepsy and brain tumors, through functional imaging.
• Others: Includes applications in bone scanning and infection imaging, contributing to comprehensive diagnostic capabilities.

By End User:

• Hospitals: Leading end users with 41.3% market share in 2024, due to extensive infrastructure and diverse diagnostic needs.
• Ambulatory Surgical Centers: Adopt mobile gamma cameras for their portability and efficiency in outpatient surgical procedures.
• Research Centers: Utilize these devices for clinical studies and the development of new diagnostic techniques.
• Imaging Centers and Clinics: Implement mobile gamma cameras to offer specialized imaging services with flexibility and reduced operational costs.

By Region:

• • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

REGIONAL INSIGHTS

North America leads the mobile gamma cameras market, holding over 35.0% share in 2024. The region's advanced healthcare infrastructure, high prevalence of chronic diseases, and rapid adoption of modern medical technologies contribute to this dominance. Supportive government healthcare initiatives and the presence of key market players further bolster market growth in this region.

RECENT DEVELOPMENTS & NEWS

• October 2024: Serac Imaging Systems announced promising clinical findings for Seracam®, a portable gamma-optical camera, in sentinel lymph node imaging for breast cancer. The device offers visual imaging alongside gamma radiation detection, enhancing anatomical context and precision.
• August 2024: Royal Shrewsbury Hospital introduced a new gamma camera as part of a £3.6 million investment to improve cancer and acute condition diagnostics. The advanced camera enhances image quality, reduces waiting times, and supports expanded imaging services.
• February 2024: M3D, Inc. received investment from Michigan Rise Pre-Seed Fund III to advance its gamma radiation detection cameras. The funding will aid in finalizing design and conducting field testing, with a commercial release expected by mid-2024. 

KEY PLAYERS

CMR Naviscan Corporation, Crystal Photonics GmbH, DDD-Diagnostic A/S, Digirad Corporation, Dilon Medical Technologies Inc., GAEDE Medizinsysteme GmbH, Mediso Ltd., MiE GmbH, Oncovision Inc., Siemens AG and Spectrum Dynamics Medical (Biosensors International Group Ltd.)

Ask Analyst for Customization: 

https://www.imarcgroup.com/request?type=report&id=5895&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:
IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: (+1-201971-6302)